Katherine S. Carroll, MD
Katherine S. Carroll, MD, is chief and assistant professor of Comprehensive Neurology in the Department of Neurology. She is also the medical director of the Comprehensive Headache Center at Northwestern Memorial Hospital, which aims to keep migraines out of the emergency room and treat complex headache conditions more effectively. Dr. Carroll’s other clinical interests include seizure disorders, neuromuscular disorders, electromyography and women’s health. |
Sherry H-Y Chou, MD
Sherry H-Y Chou, MD, is chief and associate professor of Neurocritical Care in the Department of Neurology. Her research focuses on the role of inflammation and immune response in vascular brain injuries and biomarker discovery. Dr. Chou founded and leads the large Global Consortium Study on Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID) and serves as an invited member to the World Health Organization forum on the neurological impacts of COVID-19. She serves on the board of directors and as research subcommittee chair of the Neurocritical Care Society. |
Amy B. Heimberger, MD, PhD
Amy B. Heimberger, MD, PhD, an accomplished neurosurgeon and an international leader in brain tumor research, is the scientific director of Lou and Jean Malnati Brain Tumor Institute at Robert H. Lurie Comprehensive Cancer Center at Northwestern Medicine, the vice chair of research for Neurosurgery and the Jean Malnati Miller Professor of Neurological Surgery. Dr. Heimberger specializes in awake craniotomies and brain mapping. As a researcher, she focuses on immune therapeutic strategies for patients with central nervous system malignancies and tumor-mediated mechanisms of immune suppression. She has been involved in a wide variety of bench-to-bedside immune therapeutics, including those developed in her laboratory and arising from her own patents. In 2021, she was named by President Joe Biden to the National Cancer Advisory Board. |
Tanya Simuni, MD
Tanya Simuni, MD, serves as chief of Movement Disorders in the Department of Neurology, director of the Parkinson’s Disease and Movement Disorders Center and the Arthur C. Nielsen, Jr., Research Professor of Parkinson’s Disease and Movement Disorders. The multidisciplinary movement disorders center she leads has been recognized as a Center of Excellence by the National Parkinson’s Foundation, Wilson’s Foundation and Huntington Disease Society of America, and serves as a regional training model. Dr. Simuni’s research focuses on the development of disease-modifying interventions in Parkinson’s disease. She is the principal investigator for several ongoing clinical trials, including those testing novel therapeutics. Notably, she leads the Parkinson’s Progression Markers Initiative (PPMI), a trial that could produce the largest benefit without testing drugs, and has published extensively using PPMI data. |
Lesli E. Skolarus, MD
Lesli E. Skolarus, MD, is vice chair of Faculty Development and chief of Stroke and Vascular Neurology in the Department of Neurology and Implementation Science in the Department of Medical Social Sciences. Her research focuses on promoting health equity and improving neurologic outcomes using community-based participatory research, health services research and implementation science approaches. Dr. Skolarus also serves on the American Neurological Association’s Board of Directors; co-chairs the American Neurological Association’s IDEAS (Inclusion, Diversity, Equity, Antiracism, Social justice) Task Force; and is a member of the National Institute of Neurological Disorders and Stroke Health Disparities Steering Committee, where she co-leads the Social Determinants of Health Framework subcommittee. |
Farzaneh A. Sorond, MD, PhD
Farzaneh A. Sorond, MD, PhD, is the vice dean of Faculty Affairs and director of the Simpson Querrey Center for Neurovascular Sciences at Northwestern Medicine. She is also the Dean Richard H. Young and Ellen Stearns Young Professor and professor of Stroke and Vascular Neurology and of Neurocritical Care. Since joining Northwestern Medicine, Dr. Sorond has played an important role in developing clinical programs and supporting the career development of faculty members in the Department of Neurology while also carrying out a research program focused on the association between cerebral blood flow regulation, structural changes in the brain and clinical outcomes of cerebrovascular injury. She has made multiple significant scientific discoveries that have advanced our understanding of brain vascular aging and cerebral small vessel function focused primarily on age-related brain white matter lesions (WML) and the accompanying decline in cognition and mobility. |
Phyllis C. Zee, MD, PhD
Phyllis C. Zee, MD, PhD, is the director of the Center for Circadian and Sleep Medicine, chief of Sleep Medicine in the Department of Neurology and the Benjamin and Virginia T. Boshes Professor of Neurology. Dr. Zee is a leader in the field of sleep and circadian disorders, with hundreds of publications spanning basic science investigation into circadian rhythms to clinical research examining the relationship between sleep and cardiovascular outcomes. Dr. Zee is also the founder of the first circadian medicine clinic in the U.S. The clinic is part of the Northwestern Medicine Sleep Health Centers. She has served as president of the Sleep Research Society, president of the Sleep Research Foundation and chair of the NIH Sleep Disorders Research Advisory Board, and she is currently president of the World Sleep Society. In 2021, Dr. Zee received the Lifetime Achievement Award from the National Sleep Foundation. |
About Us Terms of Use Privacy Policy How to Vote for U.S. News & World Report Best Hospitals
© 2024 Northwestern Medicine® and Northwestern Memorial HealthCare. Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University |